Plain-English translation of NCT07485738 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The SMARTFLOW:Patency trial is testing a technique called transit-time flow measurement (TTFM)—a real-time monitoring tool used during heart bypass surgery to check how well the new grafts are working right away. Some patients will have their surgeon use this flow measurement during surgery, while others will receive standard care without it. The goal is to see whether this extra monitoring helps prevent graft failure and improves recovery after surgery.
After heart bypass surgery, some grafts can fail or narrow over time, which can lead to another heart problem down the road. Doctors want to know whether checking blood flow during surgery—while they can still fix any problems—helps keep grafts open longer and patients healthier.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to either receive the blood flow monitoring during your bypass surgery or to have standard surgery without it. You will then return for follow-up appointments where your doctors will assess your recovery, check how well your grafts are working (including with imaging scans), and ask you questions about your quality of life. The study involves about 1,242 patients across multiple hospitals and will track your health over time to see whether the real-time monitoring made a difference in how well you recover.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
United States